Management of anticoagulation in patients with infective endocarditis.

[1]  Zhenhua Wang,et al.  Anticoagulation in cardiomyopathy: unravelling the hidden threat and challenging the threat individually , 2021, ESC heart failure.

[2]  B. Prendergast,et al.  2021 ESC/EACTS Guidelines for the management of valvular heart disease. , 2021, European heart journal.

[3]  W. Ge,et al.  Anticoagulation Resumption in a Patient With Mechanical Heart Valves, Antithrombin Deficiency, and Hemorrhagic Transformation Following Thrombectomy After Ischemic Stroke , 2020, Frontiers in Pharmacology.

[4]  M. Mack,et al.  2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2020, Journal of the American College of Cardiology.

[5]  K. Mahaffey,et al.  2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee. , 2020, Journal of the American College of Cardiology.

[6]  W. Tan,et al.  The effect of pre-existing anticoagulation on cerebrovascular events in left-sided infective endocarditis. , 2020, The American journal of medicine.

[7]  A. Cheung,et al.  American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support. , 2020, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[8]  M. Humbert,et al.  2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): supplementary data , 2019 .

[9]  A. Singhal,et al.  Mechanical Thrombectomy in Stroke from Infective Endocarditis: Case Report and Review. , 2019, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[10]  O. Alfieri,et al.  Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. , 2019, European heart journal.

[11]  B. Iung,et al.  Infective endocarditis: innovations in the management of an old disease , 2019, Nature Reviews Cardiology.

[12]  A. Tincani,et al.  Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. , 2018, Blood.

[13]  Andrew Wang,et al.  Management Considerations in Infective Endocarditis: A Review , 2018, JAMA.

[14]  D. Raoult,et al.  Intracranial haemorrhage in infective endocarditis. , 2018, Archives of cardiovascular diseases.

[15]  M. Gurol,et al.  Updates on Prevention of Cardioembolic Strokes , 2018, Journal of stroke.

[16]  G. Fink,et al.  Management of therapeutic anticoagulation in patients with intracerebral haemorrhage and mechanical heart valves , 2018, European heart journal.

[17]  J. Coselli,et al.  The American Association for Thoracic Surgery ( AATS ) consensus guidelines : Surgical treatment of infective endocarditis : Executive summary , 2017 .

[18]  K. Asplund,et al.  Optimal Timing of Anticoagulant Treatment After Intracerebral Hemorrhage in Patients With Atrial Fibrillation , 2017, Stroke.

[19]  S. Verma,et al.  Surgical Management of Infective Endocarditis Complicated by Embolic Stroke: Practical Recommendations for Clinicians , 2016, Circulation.

[20]  P. Kirchhof,et al.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, European heart journal.

[21]  B. Prendergast,et al.  Infective endocarditis , 2016, The Lancet.

[22]  J. Zamorano,et al.  [2015 ESC Guidelines for the management of infective endocarditis]. , 2015, Kardiologia polska.

[23]  A. Bolger,et al.  Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association , 2015, Circulation.

[24]  C. Anderson,et al.  Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2015, Stroke.

[25]  B. Iung,et al.  The optimal management of anti-thrombotic therapy after valve replacement: certainties and uncertainties. , 2014, European heart journal.

[26]  Jinsik Park,et al.  Usefulness of Anticoagulant Therapy in the Prevention of Embolic Complications in Patients with Acute Infective Endocarditis , 2014, BioMed research international.

[27]  Thoralf M Sundt,et al.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.

[28]  A. T. Santos,et al.  Efficacy and safety of low molecular weight heparin in patients with mechanical heart valves: systematic review and meta‐analysis , 2014, Journal of thrombosis and haemostasis : JTH.

[29]  B. Iung,et al.  Brain MRI Findings in Neurologically Asymptomatic Patients with Infective Endocarditis , 2013, American Journal of Neuroradiology.

[30]  D. Atar,et al.  Mass screening for silent atrial fibrillation in high risk patients - preliminary results from the STROKESTOP trial , 2013 .

[31]  C. Hidalgo-Tenorio,et al.  Neurological Complications of Infective Endocarditis: Risk Factors, Outcome, and Impact of Cardiac Surgery A Multicenter Observational Study , 2013, Circulation.

[32]  B. Iung,et al.  Infective Endocarditis with Symptomatic Cerebral Complications: Contribution of Cerebral Magnetic Resonance Imaging , 2013, Cerebrovascular Diseases.

[33]  B. Iung,et al.  Respective effects of early cerebral and abdominal magnetic resonance imaging on clinical decisions in infective endocarditis. , 2012, European heart journal cardiovascular Imaging.

[34]  R. Whitlock,et al.  Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[35]  Keiko Nagano,et al.  Cerebral Microbleeds Predict Impending Intracranial Hemorrhage in Infective Endocarditis , 2011, Cerebrovascular Diseases.

[36]  Hyuk-Jae Chang,et al.  Hemorrhagic Transformation of Ischemic Stroke: Severe Complications of Prosthetic Valve Endocarditis , 2011, Korean circulation journal.

[37]  F. Tubach,et al.  Neurologic complications and outcomes of infective endocarditis in critically ill patients: The ENDOcardite en REAnimation prospective multicenter study* , 2011, Critical care medicine.

[38]  C. Molina,et al.  Anticoagulation in patients with stroke with infective endocarditis: the sword of Damocles. , 2011, Stroke.

[39]  C. Hassager,et al.  Warfarin therapy and incidence of cerebrovascular complications in left-sided native valve endocarditis , 2011, European Journal of Clinical Microbiology & Infectious Diseases.

[40]  B. Iung,et al.  Effect of Early Cerebral Magnetic Resonance Imaging on Clinical Decisions in Infective Endocarditis , 2010, Annals of Internal Medicine.

[41]  C. Foroulis,et al.  Acute mechanical prosthetic valve thrombosis after initiating oral anticoagulation therapy. Is bridging anticoagulation with heparin required? , 2009, Interactive cardiovascular and thoracic surgery.

[42]  C. Hassager,et al.  Major Cerebral Events in Staphylococcus Aureus Infective Endocarditis: Is Anticoagulant Therapy Safe? , 2009, Cardiology.

[43]  A. Mark,et al.  Subclinical Brain Embolization in Left-Sided Infective Endocarditis: Results From the Evaluation by MRI of the Brains of Patients With Left-Sided Intracardiac Solid Masses (EMBOLISM) Pilot Study , 2009, Circulation.

[44]  Andrew Wang,et al.  Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. , 2009, Archives of internal medicine.

[45]  Stamatios Lerakis,et al.  The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). , 2007, American heart journal.

[46]  Werner Poewe,et al.  Neurological Outcome of Septic Cardioembolic Stroke After Infective Endocarditis , 2006, Stroke.

[47]  Y. Que,et al.  New concepts in the pathophysiology of infective endocarditis , 2006, Current infectious disease reports.

[48]  K. Friedman,et al.  Urgent reversal of warfarin with prothrombin complex concentrate , 2006, Journal of thrombosis and haemostasis : JTH.

[49]  Gilbert Habib,et al.  Risk of Embolism and Death in Infective Endocarditis: Prognostic Value of Echocardiography: A Prospective Multicenter Study , 2005, Circulation.

[50]  D. Moher,et al.  A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. , 2003, Journal of the American College of Cardiology.

[51]  Leonardo Mancini,et al.  Risk of embolization after institution of antibiotic therapy for infective endocarditis. , 2002, Journal of the American College of Cardiology.

[52]  D Raoult,et al.  Echocardiography predicts embolic events in infective endocarditis. , 2001, Journal of the American College of Cardiology.

[53]  J Nikoskelainen,et al.  Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland. , 2000, Archives of internal medicine.

[54]  M R Yeaman,et al.  Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects. , 1999, Circulation.

[55]  P. Tornos,et al.  Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy. , 1999, Archives of internal medicine.

[56]  P. Nihoyannopoulos,et al.  Aspirin to prevent growth of vegetations and cerebral emboli in infective endocarditis , 1992, Journal of internal medicine.

[57]  J. Delahaye,et al.  Cerebrovascular accidents in infective endocarditis: role of anticoagulation. , 1990, European heart journal.

[58]  R. L. Thompson,et al.  Anticoagulant Therapy and Central Nervous System Complications in Patients with Prosthetic Valve Endocarditis , 1978, Circulation.

[59]  M. Kupersmith,et al.  Intracranial Hemorrhage and Infarction in Anticoagulated Patients with Prosthetic Heart Valves , 1978, Stroke.

[60]  J. Alpert,et al.  Pathogenesis of Osler's nodes. , 1976, Annals of internal medicine.

[61]  V. Fowler,et al.  Infective endocarditis , 2016, Nature Reviews Disease Primers.

[62]  K. Werdan,et al.  Mechanisms of infective endocarditis: pathogen–host interaction and risk states , 2014, Nature Reviews Cardiology.